BNP Paribas Financial Markets’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $69.1M | Buy |
304,725
+52,536
| +21% | +$9.36M | 0.02% | 605 |
|
|
2026
Q1 | $43.5M | Buy |
252,189
+89,449
| +55% | +$16.6M | 0.02% | 748 |
|
|
2025
Q4 | $32.5M | Buy |
162,740
+52,861
| +48% | +$9.59M | 0.01% | 904 |
|
|
2025
Q3 | $17.2M | Buy |
109,879
+20,224
| +23% | +$3.21M | 0.01% | 1198 |
|
|
2025
Q2 | $13.6M | Sell |
89,655
-4,978
| -5% | -$664K | 0.01% | 1241 |
|
|
2025
Q1 | $14.2M | Buy |
94,633
+4,550
| +5% | +$763K | 0.01% | 1207 |
|
|
2024
Q4 | $16.6M | Buy |
90,083
+10,912
| +14% | +$2.1M | 0.01% | 1099 |
|
|
2024
Q3 | $15.6M | Sell |
79,171
-48,659
| -38% | -$10.1M | 0.01% | 976 |
|
|
2024
Q2 | $26.4M | Buy |
127,830
+60,682
| +90% | +$13.7M | 0.02% | 657 |
|
|
2024
Q1 | $18.2M | Buy |
67,148
+20,941
| +45% | +$5M | 0.02% | 823 |
|
|
2023
Q4 | $10.9M | Sell |
46,207
-1,437
| -3% | -$283K | 0.01% | 987 |
|
|
2023
Q3 | $9.34M | Buy |
47,644
+7,542
| +19% | +$1.55M | 0.01% | 928 |
|
|
2023
Q2 | $8.43M | Sell |
40,102
-39,236
| -49% | -$7.81M | 0.01% | 980 |
|
|
2023
Q1 | $16M | Buy |
79,338
+16,840
| +27% | +$3.82M | 0.02% | 684 |
|
|
2022
Q4 | $13.6M | Buy |
62,498
+13,436
| +27% | +$2.93M | 0.02% | 823 |
|
|
2022
Q3 | $9.66M | Sell |
49,062
-21,762
| -31% | -$4.7M | 0.02% | 994 |
|
|
2022
Q2 | $15.2M | Buy |
70,824
+53,655
| +313% | +$13.1M | 0.02% | 703 |
|
|
2022
Q1 | $4.88M | Sell |
17,169
-18,088
| -51% | -$5.58M | 0.01% | 1313 |
|
|
2021
Q4 | $13.3M | Sell |
35,257
-16,869
| -32% | -$6.55M | 0.02% | 830 |
|
|
2021
Q3 | $21.5M | Buy |
52,126
+512
| +1% | +$213K | 0.03% | 573 |
|
|
2021
Q2 | $19.1M | Buy |
51,614
+28,542
| +124% | +$9.53M | 0.03% | 665 |
|
|
2021
Q1 | $6.69M | Buy |
23,072
+14,384
| +166% | +$4M | 0.01% | 1009 |
|
|
2020
Q4 | $2.17M | Sell |
8,688
-7,144
| -45% | -$1.7M | ﹤0.01% | 1592 |
|
|
2020
Q3 | $3.59M | Buy |
15,832
+8,290
| +110% | +$1.72M | 0.01% | 1239 |
|
|
2020
Q2 | $1.31M | Sell |
7,542
-19,091
| -72% | -$3.05M | ﹤0.01% | 1671 |
|
|
2020
Q1 | $3.36M | Sell |
26,633
-52,493
| -66% | -$7.87M | 0.01% | 1197 |
|
|
2019
Q4 | $12.1M | Sell |
79,126
-5,449
| -6% | -$754K | 0.02% | 728 |
|
|
2019
Q3 | $11.2M | Sell |
84,575
-49,074
| -37% | -$6.58M | 0.02% | 725 |
|
|
2019
Q2 | $19M | Buy |
133,649
+110,985
| +490% | +$15.1M | 0.04% | 471 |
|
|
2019
Q1 | $3.29M | Buy |
22,664
+15,927
| +236% | +$2.09M | 0.01% | 1170 |
|
|
2018
Q4 | $762K | Sell |
6,737
-29,670
| -81% | -$3.71M | ﹤0.01% | 1685 |
|
|
2018
Q3 | $4.9M | Buy |
36,407
+23,484
| +182% | +$2.9M | 0.01% | 1148 |
|
|
2018
Q2 | $1.45M | Sell |
12,923
-20,807
| -62% | -$2.25M | ﹤0.01% | 1619 |
|
|
2018
Q1 | $3.6M | Buy |
33,730
+17,846
| +112% | +$1.92M | 0.01% | 1141 |
|
|
2017
Q4 | $1.74M | Sell |
15,884
-6,119
| -28% | -$666K | ﹤0.01% | 1570 |
|
|
2017
Q3 | $2.38M | Sell |
22,003
-3,315
| -13% | -$341K | 0.01% | 1059 |
|
|
2017
Q2 | $2.56M | Buy |
25,318
+5,743
| +29% | +$529K | 0.01% | 1056 |
|
|
2017
Q1 | $1.76M | Sell |
19,575
-982
| -5% | -$83.4K | ﹤0.01% | 1117 |
|
|
2016
Q4 | $1.57M | Sell |
20,557
-150,020
| -88% | -$11.4M | 0.01% | 1079 |
|
|
2016
Q3 | $14.2M | Buy |
170,577
+144,702
| +559% | +$12.1M | 0.06% | 227 |
|
|
2016
Q2 | $2.13M | Sell |
25,875
-3,636
| -12% | -$299K | 0.01% | 841 |
|
|
2016
Q1 | $2.24M | Buy |
29,511
+19,572
| +197% | +$1.45M | 0.01% | 784 |
|
|
2015
Q4 | $799K | Sell |
9,939
-1,057
| -10% | -$76.2K | ﹤0.01% | 979 |
|
|
2015
Q3 | $698K | Buy |
10,996
+1,133
| +11% | +$81.4K | ﹤0.01% | 1199 |
|
|
2015
Q2 | $694K | Buy |
9,863
+8,147
| +475% | +$603K | ﹤0.01% | 1234 |
|
|
2015
Q1 | $136K | Buy |
1,716
+733
| +75% | +$54.1K | ﹤0.01% | 1661 |
|
|
2014
Q4 | $62.6K | Sell |
983
-4,707
| -83% | -$295K | ﹤0.01% | 1637 |
|
|
2014
Q3 | $340K | Sell |
5,690
-888
| -13% | -$50.8K | ﹤0.01% | 1666 |
|
|
2014
Q2 | $352K | Sell |
6,578
-1,867
| -22% | -$102K | ﹤0.01% | 1627 |
|
|
2014
Q1 | $454K | Buy |
8,445
+7,479
| +774% | +$436K | ﹤0.01% | 1480 |
|
|
2013
Q4 | $51.2K | Buy |
+966
| New | +$48.5K | ﹤0.01% | 1907 |
|
Other funds holding CRL
AI
BNP Paribas Financial Markets's CRL Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Charles River Laboratories (CRL) stake by 21% in Q2 2026, buying an estimated $9.36M and bringing the position to 304,725 shares worth $69.1M. The position accounts for 0.02% of the portfolio, ranked #605.
BNP Paribas Financial Markets first reported a position in CRL in Q4 2013 and has held it in 51 quarters since. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- BNP Paribas Financial Markets held 304,725 shares of Charles River Laboratories worth $69.1M as of Q2 2026.
- BNP Paribas Financial Markets bought 52,536 Charles River Laboratories shares in Q2 2026, an estimated $9.36M.
- Charles River Laboratories made up 0.02% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #605 holding.
- BNP Paribas Financial Markets first reported a position in Charles River Laboratories in Q4 2013 and has held it in 51 quarters since.
- 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.